Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2551.27	16072.27	-606.21
Graham Fair Price	-67.14	709.91	2160.59
PEG	8739.41	16.94	0.19
Price/Book	-7.36	10.90	11.76
Price/Cash Flow	-89.29	-234.13	2187.04
Prices/Earnings	-685.87	-1502.74	-191.22
Price/Sales	-17.52	56.95	69.04
Price/FCF	-89.29	-234.13	2187.04
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	19.28	0.54	0.45
Operating Margin	-97.50	< 0.005	-0.14
ROA	87.79	< 0.005	-0.01
ROE	-0.02	< 0.005	88.21
ROIC	-0.01	< 0.005	-61.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	0.16	-70.39
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-49.45	1.03	-97.92
EPS QOQ	-9.98	0.89	-91.11
FCF QOQ	-0.95	-9.28	-879.85
Revenue QOQ	-0.04	0.07	97.39
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	166.99	179.51	7.50
Days Sales Outstanding (DSO)	63.99	57.60	-9.98
Inventory Turnover	0.54	0.50	-6.97
Debt/Capitalization	< 0.005	< 0.005	-39.30
Quick Ratio	2.10	2.36	12.43
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3673.44	3515.36	-4.30
Cash	1114.49	950.47	-14.72
Capex	-39.55	-80.36	-103.20
Free Cash Flow	19.75	-163.58	728.14
Revenue	625.69	672.56	7.49
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.02	3.50	15.98
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.11	-243.25	2569.34
Naive Interpretation	Member

06 - Financial Health · Bad

Rating